#United States #Irvine #Allergan Aesthetics #AA Signature #AMWC 2026

Allergan Aesthetics Introduces Comprehensive Innovations in Aesthetic Treatments

In a groundbreaking announcement, Allergan Aesthetics, a leader in medical aesthetics and part of AbbVie, unveiled its latest consumer research, signaling an exciting change in patient expectations within the aesthetics sector. The findings from a global study of over 12,000 participants across nine countries reveal a significant shift towards more holistic and multimodal treatment approaches that prioritize natural results.

Evolution in Patient Preferences

Mark Wilson, Senior Vice President for Allergan Aesthetics, stated, "Medical aesthetics is entering an exciting era, where patients are embracing a broader, more holistic perspective on their treatment journeys." This sentiment underscores the transformation in patient attitudes, which increasingly favor structured, bespoke treatment plans that guide them towards authentic, natural-looking outcomes. Notably, the survey showed that 62% of respondents were open to multiple aesthetic treatments, highlighting a departure from isolated, single interventions.

Insights from the Global Survey

The study, one of the largest of its kind, sought to explore aesthetic treatment preferences. It revealed that an astounding 78% of individuals would feel more satisfied working with their practitioner on a long-term plan, hinting at the growing importance of collaboration in the aesthetic journey. Additionally, 74% expressed interest in improving facial skin quality, and 63% identified enhancing skin elasticity and addressing visible signs of aging as their primary aesthetic goals. These insights not only reflect changing consumer attitudes but also the evolving role of healthcare professionals in shaping treatment decisions.

The Next Step: AA Signature™ Framework

At the upcoming Aesthetic and Anti-Aging Medicine World Congress (AMWC) 2026 in Monaco, Allergan Aesthetics will present the next evolution of its AA Signature™ framework, designed to support personalized, multimodal treatment planning. The AA Signature™ framework was developed in collaboration with industry experts to ensure it meets the dynamic needs of patients seeking integrated treatment options. The updated framework will introduce elevated looks and expanded indications that align with contemporary patient expectations.

Night of Insight and Education

During AMWC 2026, Allergan will launch a new report titled Layered Beauty: The New Aesthetic Mindset. This report will highlight insights from the latest research, including the finding that 59% of respondents would likely adopt a structured multi-treatment approach. The company is committed to continually evolving its offerings, helping practitioners deliver personalized outcomes within comprehensive aesthetic treatment plans.

The program will include two flagship symposia led by the Allergan Medical Institute (AMI), focusing on the integration of various treatment modalities within the AA Signature™ Skin360 approach. Notable experts will discuss the application of injectable products, such as Juvéderm and BOTOX™, alongside energy-based devices, showcasing how these combined treatments can enhance patient satisfaction and efficiency.

A Commitment to Innovation

Allergan's commitment to education and innovation is further exemplified by the detailed Global Medical Affairs Symposium that will take place during the congress. World-renowned experts will address current trends and unmet needs in the aesthetics field, with a strong emphasis on multimodal approaches that are becoming increasingly apparent in patient treatment journeys.

Looking Ahead

As Allergan Aesthetics heads into this new era of aesthetic treatments, the emphasis is clearly on collaboration, innovation, and holistic care. By listening to consumer needs and adapting to their preferences, Allergan is setting the standard for future practices in the aesthetics field, ultimately striving to empower practitioners and patients alike in achieving their aesthetic goals.

Through the developments showcased at AMWC 2026, Allergan Aesthetics is not only reinforcing its leadership role but also actively responding to the evolving landscape of patient expectations in aesthetic treatments. The future will undoubtedly bring more marked changes as the industry adapts to deliver the personalized and integrated care that modern patients demand.